For the quarter ended March 2025, BILL Holdings (BILL) reported revenue of $358.22 million, up 10.9% over the same period last year. EPS came in at $0.50, compared to $0.60 in the year-ago quarter.The reported revenue represents a surprise of +0.97% over the Zacks Consensus Estimate of $354.78 million. With the consensus EPS estimate being $0.37, the EPS surprise was +35.14%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Stree ...

Core Viewpoint - Globus Medical reported a decline in revenue and earnings for the quarter ended March 2025, missing Wall Street expectations, indicating potential challenges in financial performance [1][2]. Financial Performance - Revenue for the quarter was $598.12 million, down 1.4% year-over-year, and below the Zacks Consensus Estimate of $628.32 million by 4.81% [1]. - Earnings per share (EPS) were $0.68, a decrease from $0.72 in the same quarter last year, and fell short of the consensus estimate of $0.74 by 8.11% [1]. Geographic Revenue Breakdown - International revenue was reported at $114.26 million, which is 7.7% lower than the three-analyst average estimate of $127.52 million [4]. - U.S. revenue stood at $483.86 million, slightly up by 0.2% year-over-year, but below the average estimate of $510.72 million [4]. Product Category Performance - Net sales from Enabling Technologies were $22.19 million, significantly lower than the estimated $38.79 million, reflecting a year-over-year decline of 30.6% [4]. - Musculoskeletal Solutions generated $575.93 million in sales, which was marginally above the year-ago figure by 0.2%, but still below the estimated $598.85 million [4]. Stock Performance - Shares of Globus Medical have returned -3.7% over the past month, contrasting with the Zacks S&P 500 composite's increase of 11.3% [3]. - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3].

For the quarter ended March 2025, Allbirds, Inc. (BIRD) reported revenue of $32.11 million, down 18.4% over the same period last year. EPS came in at -$2.73, compared to -$3.60 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $30.87 million, representing a surprise of +4.03%. The company delivered an EPS surprise of +29.09%, with the consensus EPS estimate being -$3.85.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- ...

Sensata (ST) reported $911.26 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 9.5%. EPS of $0.78 for the same period compares to $0.89 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $879.52 million, representing a surprise of +3.61%. The company delivered an EPS surprise of +8.33%, with the consensus EPS estimate being $0.72.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how th ...

Core Insights - H&R Block, Inc. reported strong third-quarter results for fiscal 2025, with adjusted earnings of $5.38 per share, exceeding the Zacks Consensus Estimate by 5.1% and increasing 8.9% year-over-year. Total revenues reached $2.28 billion, slightly surpassing the estimate by 1.4% and growing 4.2% year-over-year [1] Financial Performance - Revenues from U.S. tax preparation and related services were $2.14 billion, down 5.2% year-over-year. Financial services revenues were $54.5 million, a decline of 12.6%. International revenues decreased by 11.5% to $60.4 million, while Wave revenues increased by 13.3% to $26.7 million [3] - The company ended the quarter with cash and cash equivalents of $773 million, down from $794.6 million year-over-year. Long-term debt decreased to $1.14 billion from $1.5 billion in the previous year. Operating activities used $429.3 million in cash, with capital expenditures at $71.8 million [4] FY25 Outlook - For fiscal 2025, H&R Block expects revenues between $3.69 billion and $3.75 billion, with a midpoint of $3.72 billion aligning with the Zacks Consensus Estimate. Adjusted EPS is projected in the range of $5.15 to $5.35, with a midpoint of $5.25 above the consensus estimate of $5.23. EBITDA is expected to be between $975 million and $1.02 billion, with an effective tax rate of 13% [5] Stock Performance - H&R Block shares have increased by 25.3% over the past year, significantly outperforming the industry, which has seen an 18% decline [2]

Altice USA, Inc. (ATUS) reported $2.15 billion in revenue for the quarter ended March 2025, representing a year-over-year decline of 4.4%. EPS of -$0.16 for the same period compares to -$0.05 a year ago.The reported revenue represents a surprise of -0.48% over the Zacks Consensus Estimate of $2.16 billion. With the consensus EPS estimate being -$0.09, the EPS surprise was -77.78%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to dete ...

TEGNA Inc. (TGNA) reported $680.05 million in revenue for the quarter ended March 2025, representing a year-over-year decline of 4.8%. EPS of $0.37 for the same period compares to $0.45 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $677.17 million, representing a surprise of +0.43%. The company delivered an EPS surprise of +8.82%, with the consensus EPS estimate being $0.34.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and h ...

For the quarter ended March 2025, Jackson Financial (JXN) reported revenue of $1.77 billion, down 36% over the same period last year. EPS came in at $5.10, compared to $4.23 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.78 billion, representing a surprise of -0.19%. The company delivered an EPS surprise of +3.45%, with the consensus EPS estimate being $4.93.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and ho ...

Core Insights - Staar Surgical reported a revenue of $42.59 million for the quarter ended March 2025, which is a 45% decrease compared to the same period last year [1] - The earnings per share (EPS) for the quarter was -$0.52, a decline from $0.06 in the year-ago quarter, but it exceeded the consensus EPS estimate of -$0.59 by 11.86% [1] - The revenue surpassed the Zacks Consensus Estimate of $40.34 million by 5.57% [1] Financial Performance - The stock of Staar Surgical has returned +23.5% over the past month, outperforming the Zacks S&P 500 composite's +10.6% change [3] - The company currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3] Geographic Sales Breakdown - In the United States, net geographic sales were $5.46 million, slightly below the average estimate of $5.82 million, representing a year-over-year increase of +10.6% [4] - In Japan, net geographic sales reached $11.39 million, exceeding the average estimate of $10.54 million, with a year-over-year change of +8.9% [4] - In China, net geographic sales were only $0.39 million, significantly lower than the estimated $1.15 million, marking a drastic year-over-year decline of -99% [4]

Zillow Group (ZG) reported $598 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 13%. EPS of $0.41 for the same period compares to $0.36 a year ago.The reported revenue represents a surprise of +1.61% over the Zacks Consensus Estimate of $588.55 million. With the consensus EPS estimate being $0.43, the EPS surprise was -4.65%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street ex ...